Arkolith/Insider Trading/CRBP/Form 4

Saxena Nishant C

Chief Business OfficerCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Jun 3, 2026
Net Buying
Open-Market Buys
$101K
Open-Market Sells
$0
Net Open-Market Flow
$101K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 3, 2026Buy(P)9K$7.58$68K75K
Jun 2, 2026Buy(P)5K$7.33$33K66K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-255834) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML